PubRank

Laura R McCabe

Author PubWeight™ 32.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice. Endocrinology 2005 1.70
2 Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice. Endocrinology 2006 1.57
3 Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab 2013 1.45
4 Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J Cell Biochem 2006 1.24
5 Inhibition of PPARgamma prevents type I diabetic bone marrow adiposity but not bone loss. J Cell Physiol 2006 1.22
6 Bone and glucose metabolism: a two-way street. Arch Biochem Biophys 2010 1.18
7 The bone marrow microenvironment contributes to type I diabetes induced osteoblast death. J Cell Physiol 2011 1.05
8 Normal bone density obtained in the absence of insulin receptor expression in bone. Endocrinology 2006 1.05
9 Streptozotocin, type I diabetes severity and bone. Biol Proced Online 2009 1.04
10 Type I diabetic bone phenotype is location but not gender dependent. Histochem Cell Biol 2007 1.00
11 Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model. J Cell Physiol 2014 0.99
12 Bone inflammation and altered gene expression with type I diabetes early onset. J Cell Physiol 2009 0.97
13 Leptin treatment prevents type I diabetic marrow adiposity but not bone loss in mice. J Cell Physiol 2009 0.96
14 Osteoblasts respond to hydroxyapatite surfaces with immediate changes in gene expression. J Biomed Mater Res A 2004 0.96
15 CCAAT/enhancer-binding protein-beta has a role in osteoblast proliferation and differentiation. Exp Cell Res 2004 0.96
16 Reduced gap junctional intercellular communication and altered biological effects in mouse osteoblast and rat liver oval cell lines transfected with dominant-negative connexin 43. Mol Carcinog 2003 0.95
17 Human bone marrow adiposity is linked with serum lipid levels not T1-diabetes. J Diabetes Complications 2012 0.93
18 β-Arrestin-1 deficiency protects mice from experimental colitis. Am J Pathol 2013 0.93
19 Simulated microgravity suppresses osteoblast phenotype, Runx2 levels and AP-1 transactivation. J Cell Biochem 2003 0.92
20 Inflammatory bowel disease causes reversible suppression of osteoblast and chondrocyte function in mice. Am J Physiol Gastrointest Liver Physiol 2009 0.92
21 MC3T3-E1 osteoblast attachment and proliferation on porous hydroxyapatite scaffolds fabricated with nanophase powder. Int J Nanomedicine 2006 0.92
22 Amelioration of type I diabetes-induced osteoporosis by parathyroid hormone is associated with improved osteoblast survival. J Cell Physiol 2012 0.91
23 Hypoxia suppresses runx2 independent of modeled microgravity. J Cell Physiol 2004 0.89
24 Colitis-induced bone loss is gender dependent and associated with increased inflammation. Inflamm Bowel Dis 2013 0.84
25 Inhibition of cross-bridge formation has no effect on contraction-associated phosphorylation of p38 MAPK in mouse skeletal muscle. Am J Physiol Cell Physiol 2004 0.83
26 P38 and activating transcription factor-2 involvement in osteoblast osmotic response to elevated extracellular glucose. J Biol Chem 2002 0.83
27 Caspase-2 deficiency protects mice from diabetes-induced marrow adiposity. J Cell Biochem 2011 0.82
28 CCAAT/enhancer binding protein β-deficiency enhances type 1 diabetic bone phenotype by increasing marrow adiposity and bone resorption. Am J Physiol Regul Integr Comp Physiol 2011 0.81
29 Both spontaneous Ins2(+/-) and streptozotocin-induced type I diabetes cause bone loss in young mice. J Cell Physiol 2013 0.80
30 Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation. J Cell Physiol 2015 0.79
31 Enhanced production of early lineages of monocytic and granulocytic cells in mice with colitis. Proc Natl Acad Sci U S A 2012 0.78
32 Low dose aspirin therapy decreases blood glucose levels but does not prevent type i diabetes-induced bone loss. Cell Physiol Biochem 2011 0.77
33 Biaxial flexure testing of calcium phosphate bioceramics for use in tissue engineering. J Biomed Mater Res A 2005 0.75
34 Adsorption of serum fetuin to hydroxylapatite does not contribute to osteoblast phenotype modifications. J Biomed Mater Res A 2005 0.75
35 Adrenomedullin increases AP-1 expression in rat mesangial cells via activation of protein kinase-A and p38 MAPK. Cell Physiol Biochem 2003 0.75
36 The effects of damage accumulation on the tensile strength and toughness of compact bovine bone. J Biomech 2013 0.75